The Eighth Annual International Employment Survey - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

The Eighth Annual International Employment Survey


Pharmaceutical Technology



Figure 2: Highest level of education.
Education and professional work experience. Fifty-two percent of employees had a degree beyond a bachelor's degree (see Figure 2). The most common fields of study were analytical chemistry and biology (or biology-related) (14.5% each). A significant number of respondents (12%) also said they earned their degree in pharmaceutics or pharmacy. Surprisingly, 9% said they had studied in a field unrelated to pharmaceutical science or industry.

Success on the job may be attributed more to experience than education, however. Sixty-four percent of respondents said their experience had prepared them "very well" for their current job function, compared with only 27% who said the same for their education. Pharmaceutical employees reported an average of 17.4 years of professional work experience, including postdoctoral study.

Employment

Type of employer. A preponderance of respondents are employed in private industry (89%), with more than one-third working at companies employing more than 10,000 people total. Those employed in academia represented 3.4% of respondents. The remaining participants were employed in either local or national government. Thus, the information provided in this article, including salary and attitudes toward current employment clearly best represents those working in the private sector.


Table II: Top five job functions.
Job description. About one in five respondents work in quality assurance and quality control (22%), followed by pharmaceutical development (11%), pharmaceutical analytical development (9%), validation (8%), and engineering or engineering management (6%) (see Table II).

Ninety-five percent of respondents are employed full-time. On average, employees are contracted to work 39 h per week, but actually work more than 46 h per week, with 89% reporting that they do not receive financial reimbursement for extra hours worked.




On average, employees have worked for their current employer for 7.6 years. As a confirmation of the activity of the pharma industry, 58% of respondents say they have been through company downsizing, restructuring, or a merger or acquisition in the past two years. Nearly an equal percentage of respondents indicated these activities have changed their job responsibilities (23%) as those who reported no significant change (28%).

Salary and benefits


Figure 3: Annual salaries of men and women.
Overall results. The mean base annual salary was $87,646 overall, and $92,412 for US respondents only (an increase of 5% over last year's average). Overall, employees reported an average of $11,309 in additional income from their principal employer, including bonuses, summer work, and grants, and an average $1576 in additional income from other professional work.




Salary according to gender only. On average, women working full time earn 82% of the average salary reported by men working full time (see Figure 3). The gap between men's and women's salaries is slightly less than it was last year, but still close to the 80% reported in the third quarter 2005 report by the US Department of Labor (1).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
21%
To all process for new products only
13%
To select process for new products only
26%
To select processes for both new and legacy products
21%
Do not use QbD
21%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
Overcoming the Challenges in Biopharmaceutical Stability Testing
PhRMA Dismayed by Special 301 Report
FindPharma Custom Search
Source: Pharmaceutical Technology,
Click here